Top Prelude Therapeutics Presentations
The most viewed presentations, reports, and documents from Prelude Therapeutics.
Prelude Therapeutics PRT543 Phase 1 Clinical Trial PRMT5 Inhibitor
conferenceconference
13 Pages
Prelude Therapeutics Investor Presentation — March 2021
investor_presentationinvestor_presentation
40 Pages
Prelude Therapeutics Investor Presentation — May 2021
investor_presentationinvestor_presentation
40 Pages
Prelude Therapeutics 2023 SVB Global Biopharma Conference
conferenceconference
31 Pages
Prelude Therapeutics Corporate Presentation 2023
investor_presentationinvestor_presentation
37 Pages
Prelude Therapeutics Corporate Presentation 2023
investor_presentationinvestor_presentation
39 Pages